| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2398 |
| Trial ID | NCT04464200 |
| Disease | Chronic Lymphocytic Leukemia | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Burkitt Lymphoma | Primary Mediastinal B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Diffuse Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma Activated B-Cell Type |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | 19(T2)28z1xx CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers |
| Year | 2020 |
| Country | United States |
| Company sponsor | Memorial Sloan Kettering Cancer Center |
| Other ID(s) | 20-167 |
| Cohort 1 | |||||||||||
|
|||||||||||